NM_005063.5(SCD):c.110C>G (p.Thr37Arg) AND not specified
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Aug 13, 2021
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV004102037.1
Allele description [Variation Report for NM_005063.5(SCD):c.110C>G (p.Thr37Arg)]
NM_005063.5(SCD):c.110C>G (p.Thr37Arg)
Condition(s)
- Synonyms:
- AllHighlyPenetrant
- Identifiers:
- MedGen: CN169374
-
Xanthomonas axonopodis strain IBSBF2421 RNA polymerase sigma factor (rpoD) gene,...
Xanthomonas axonopodis strain IBSBF2421 RNA polymerase sigma factor (rpoD) gene, partial cdsgi|1040064919|gb|KT074877.1|Nucleotide
-
Enterobacter sp. strain E3 16S ribosomal RNA gene, partial sequence
Enterobacter sp. strain E3 16S ribosomal RNA gene, partial sequencegi|1278992509|gb|MG547757.1|Nucleotide
-
Description and Appraisal of Outcome Measures - Clinical and Economic Review Rep...
Description and Appraisal of Outcome Measures - Clinical and Economic Review Report: Vedolizumab (ENTYVIO SC)
-
Definition of Statin Intensity - Clinical Review Report: Icosapent Ethyl (Vascep...
Definition of Statin Intensity - Clinical Review Report: Icosapent Ethyl (Vascepa)
-
Literature Search Strategy - Clinical Review Report: Icosapent Ethyl (Vascepa)
Literature Search Strategy - Clinical Review Report: Icosapent Ethyl (Vascepa)
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Nov 10, 2024